| |
Primary cohort
|
Validation cohort
|
|---|
|
General characteristics
| | |
|
Age
|
β = 0.02, P = 0.79
|
β = 0.03, P = 0.73
|
|
Gender
|
0.97 (0.96 to 0.99)*
|
0.98 (0.96 to 0.99)*
|
|
Disease-related characteristics
| | |
|
Log disease duration
|
β =
0.21,
p
= 0.01
|
β = 0.12, P = 0.21
|
|
RF positivity
|
0.90 (0.99 to 1.02)
|
n/a
|
|
Log ESR
|
β = -
0.20,
P
= 0.01
|
β= -0.144, P = 0.131
|
|
Log CRP
|
β = -
0.23,
P
= 0.003
|
β = -
0.28,
P
= 0.002
|
|
DAS28
|
β = -0.12, P = 0.09
|
n/a
|
|
HAQ
|
β = -0.11, P = 0.16
|
n/a
|
|
Classical CVD risk factors
| | |
|
Body mass index
|
β = - 0.13, P = 0.05
|
β = - 0.19, P = 0.18
|
|
Pulse pressure
|
β = -
0.23,
P
= 0.004
|
β = -
0.21,
P
= 0.017
|
|
Mean blood pressure
|
β = -0.10, P = 0.15
|
β = -0.17, P = 0.05
|
|
Heart rate
|
β =
-0.64,
P
< 0.001
|
β = -
0.76
P
< 0.001
|
|
Total cholesterol
|
β = -0.12, P = 0.09
|
β = -0.14, P = 0.14
|
|
TC:HDL ratio
|
β = -0.02, P = 0.76
|
β = -0.09, P = 0.35
|
|
Triglycerides
|
β = -0.01, P = 0.90
|
β = 0.01, P = 0.94
|
- Data presented as β and P values or odds ratio (95% confidence interval). CRP, C reactive protein; CVD, cardiovascular disease; DAS28, Disease Activity Score in 28 joints; ESR, erythrocyte sedimentation rate; HAQ, Health Assessment Questionnaire; HDL, high density lipoprotein; n/a, not available; RF, rheumatoid factor; SEVR, subendocardial viability ratio; TC, total cholesterol. *P < 0.001. Bold data represent statistically significant results.
